2011 COVID-19 FDA 
Healthcare It News
FEBRUARY 1, 2022
Another result concerns innovation through ‘femtech’: digital technologies and applications related to women’s health are increasingly gaining importance – more so as this has been a gap in care in the US with only three per cent of all health deals since 2011 focusing on this area.
Healthcare It News
FEBRUARY 1, 2022
Another result concerns innovation through ‘femtech’: digital technologies and applications related to women’s health are increasingly gaining importance – more so as this has been a gap in care in the US with only three per cent of all health deals since 2011 focusing on this area.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
JUNE 27, 2023
New research from Mayo Clinic Proceedings found that 63% of physicians report at least one symptom of burnout, a drastic increase from 46% in 2011. A digital solution should also offer personalized integration with ongoing support, feature enhancements and updates.
Healthcare It News
MARCH 18, 2022
What has been one digital health investment trend during the COVID-19 pandemic, and why is it important? Before COVID-19, a few companies, such as Livongo, made a splash in the digital health community by going public – Livongo in July 2019. Worse yet, COVID-19 has exacerbated mental and behavioral health issues.
Hall Render
AUGUST 31, 2023
Food & Drug Administration (“FDA”) approval and regulation of mifepristone (brand name Mifeprex), a drug used in medically induced abortions. The panel vacated in part and affirmed in part a decision by a District Court judge in Texas that would have suspended the FDA’s approval of mifepristone. Jackson Women’s Health.
SQA
FEBRUARY 15, 2023
” The reason: The existing document of the EU GMP Guideline dates back to 2011 and no longer corresponds to the state of the art in various areas or does not consider increasingly important new technologies for the GMP field, according to the EMA. ” The requirements for providers (e.g.,
SQA
JUNE 3, 2024
9 Lessons Learned from the COVID-19 Pandemic, January 2024 As a result of the COVID-19 pandemic, many industries (the pharmaceutical included) went through a substantial disruption. For many pharmaceutical companies, challenges increased as they raced to provide a vaccine or a therapeutic treatment for COVID-19.
Expert insights. Personalized for you.
258 
Let's personalize your content